Skip to main content
. 2023 Jun 29;22:162. doi: 10.1186/s12933-023-01899-0

Fig. 2.

Fig. 2

Cardioprotective actions of Finerenone in HFpEF. MR: mineralocorticoid receptor; E: early diastolic flow velocity; e’: velocity of early diastolic mitral annular motion; IVRT: isovolumic relaxation time; GLS: global longitudinal strain; LVEDP: left ventricular end-diastolic pressure.

[adapted from “Mast Cell Key Features” template, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates]